Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | ALDH1A3 | P47895 | 5/20 | 0.33 |
| ▸ | ALDH3A1 | P30838 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12982458 | 0.83 | PDK2 (0.38) | ALDH1A1ALDH1A3ALDH3A1TSHR | |
| SCHEMBL13782166 | 0.82 | ALDH1A1 (0.34) | ALDH1A1ALDH1A3TSHRFDPSKDM4E | |
| SCHEMBL7864657 | 0.81 | ALDH1A3 (0.33) | ALDH1A1ALDH1A3ALDH3A1TSHRFDPS | |
| SCHEMBL1085980 | 0.81 | ALDH1A1 (0.41) | ALDH1A1ALDH1A3ALDH3A1TSHRFDPS | |
| SCHEMBL13180407 | 0.77 | ALDH1A1 (0.33) | ALDH1A1TSHRFDPSPTGER4 | |
| SCHEMBL13453848 | 0.77 | PDK2 (0.36) | — | |
| SCHEMBL2781069 | 0.76 | ALDH1A1 (0.38) | ALDH1A1ALDH1A3ALDH3A1KDM4E | |
| SCHEMBL13534620 | 0.76 | CHEK1 (0.37) | ALDH1A1KDM4ERAB9A | |
| SCHEMBL16359287 | 0.75 | PDK2 (0.42) | ALDH1A1TSHRPTGS2 | |
| SCHEMBL13719008 | 0.75 | ALDH1A1 (0.53) | ALDH1A1ALDH1A3KDM4ERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203066-A1 | ORGANOGOLD NONLINEAR OPTICAL CHROMOPHORES | UNIV CASE WESTERN RESERVE (US) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203066-A1 | ORGANOGOLD NONLINEAR OPTICAL CHROMOPHORES | NR2E3, OR10J3, NMBR | ALDH1A1 1513/4885ALDH1A3 122/4885ALDH3A1 798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.